Soleus Capital Management »

Cogent Biosciences shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.3M 120k 35.52

More positions owned by Soleus Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Krystal Biotech (KRYS)
Celcuity (CELC)
Novocure Ord Shs (NVCR)
Praxis Precision Medicines I Com New (PRAX)
Tg Therapeutics (TGTX)
Dex (DXCM)
BioMarin Pharmaceutical (BMRN)
Globus Med Cl A (GMED)
Beta Bionics (BBNX)
Amicus Therapeutics (FOLD)
Twist Bioscience Corp (TWST)
Organogenesis Hldgs (ORGO)
Syndax Pharmaceuticals (SNDX)
Mirum Pharmaceuticals (MIRM)

View all positions for Soleus Capital Management

Top funds holding Cogent Biosciences

FMR
BlackRock
Vanguard Group
Deerfield Management Company
Fairmount Funds Management
Rtw Investments
Kynam Capital Management
TCG Crossover Management
State Street Corporation
Geode Capital Management
Henderson Group
Balyasny Asset Management
Vivo Capital
Octagon Capital Advisors
Duquesne Family Office

View all funds holding Cogent Biosciences